NDC 0517-1820
Chlorothiazide Sodium
Chlorothiazide Sodium
Chlorothiazide Sodium is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by American Regent, Inc.. The primary component is Chlorothiazide Sodium.
| Product ID | 0517-1820_2c97dd4f-150c-4fc0-9400-2d8305bb21b0 |
| NDC | 0517-1820 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Chlorothiazide Sodium |
| Generic Name | Chlorothiazide Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-04-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202561 |
| Labeler Name | American Regent, Inc. |
| Substance Name | CHLOROTHIAZIDE SODIUM |
| Active Ingredient Strength | 500 mg/18mL |
| Pharm Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |